The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

Share Price Information for Phoenix Group Holdings (PHNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 503.00
Bid: 504.50
Ask: 505.50
Change: 7.00 (1.41%)
Spread: 1.00 (0.198%)
Open: 490.80
High: 505.50
Low: 490.80
Prev. Close: 496.00
PHNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Secondary Placing in Phoenix Group Hldgs

11 Jan 2022 17:09

RNS Number : 1238Y
Merrill Lynch International
11 January 2022
 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

 

PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

11 January 2022

Proposed Secondary Placing of approximately 66 million ordinary shares inPhoenix Group Holdings plc ("Phoenix" or the "Company")

 

Merrill Lynch International ("BofA Securities") (the "Sole Bookrunner") has been appointed by Swiss Re Finance Midco (Jersey) Limited (an entity wholly owned by Swiss Re Group) (the "Seller") as Sole Global Coordinator and Sole Bookrunner in relation to a proposed secondary sale of approximately 66 million ordinary shares ("Placing Shares") in the capital of Phoenix to institutional investors (the "Placing"). The Placing Shares represent approximately 6.6 per cent of Phoenix's issued share capital.

 

Swiss Re Finance Midco (Jersey) Limited currently owns 66,199,917 ordinary shares, corresponding to approximately 6.6 per cent of the Company's entire issued share capital.

 

The price per Placing Share will be determined by way of an accelerated bookbuilding process. The bookbuilding period will commence today, 11 January 2022, with immediate effect and may close at any time on short notice. The results of the Placing will be announced as soon as practicable after the closing of the bookbuilding process.

 

Phoenix is not a party to the Placing and will not receive any proceeds from the Placing.

 

Enquiries

 

BofA Securities +44 (0) 20 7628 1000

Jonathan Alpert

Ed Peel

James Palmer

Oliver Elias

 

 

IMPORTANT NOTICE

 

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

 

This announcement is not for publication, release or distribution, directly or indirectly, in whole or in part, in or into the United States, Australia, Canada, Japan, The Republic of South Africa or any other jurisdiction in which offers or sales would be prohibited by applicable law. The publication, release or distribution of this announcement and the offer and sale of the Shares in certain jurisdictions may be restricted by law and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

The Shares are not being offered to the public in any jurisdiction and may not be offered to the public in any jurisdiction in circumstances which would require the preparation or registration of any prospectus or offering document relating to the shares in such jurisdiction. This announcement is not an offer of, or solicitation of an offer to buy, securities for sale in the United States, Australia, Canada, Japan or the Republic of South Africa or in any jurisdiction to whom or in which such offer or solicitation is unlawful. No action has been taken by the Seller, Merrill Lynch International or any of their affiliates to permit a public offering of the shares or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or purchase whatsoever in any jurisdiction.

 

The securities referred to herein have not been registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and the securities laws of any state or other jurisdiction of the United States.

 

No prospectus or offering document has been or will be prepared in connection with the Placing. The publicly available information of the Company is not the responsibility of, and has not been independently verified by, the Seller, Merrill Lynch International, or any of their respective affiliates.

 

In member states of the European Economic Area (the "EEA"), this announcement and the Placing are directed exclusively at persons who are "qualified investors" within the meaning of the Regulation (EU) 2017/1129 ("Qualified Investors"). In the United Kingdom this announcement and the Placing are directed exclusively at persons who are "qualified investors" within the meaning of the Regulation (EU) 2017/1129 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) who fall within Article 49(2)(A) to (D) of the Order, or (iii) to whom it may otherwise lawfully be communicated (all such persons together being referred to herein as "Relevant Persons"). This announcement must not be acted on or relied on by persons in member states of the EEA who are not Qualified Investors and persons in the United Kingdom who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to persons in member states of the EEA who are Qualified Investors and persons in the United Kingdom who are Relevant Persons and will be engaged in only with such persons. 

 

Merrill Lynch International is authorised by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority. Merrill Lynch International is acting exclusively for the Seller and no-one else in connection with the Placing. They will not regard any other person as their respective clients in relation to the Placing and will not be responsible to anyone other than the Seller for providing the protections afforded to their respective clients, nor for providing advice in relation to the Placing, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

 

In connection with the Placing, Merrill Lynch International and any of its respective affiliates, may take up a portion of the Placing Shares as a principal position and in that capacity may retain, purchase, sell, offer to sell for their own accounts such Placing Shares and other securities of the Company or related investments in connection with the Placing or otherwise. In addition Merrill Lynch International and any of its respective affiliates may enter into financing arrangements (including swaps, warrants or contracts for differences) with investors in connection with which Merrill Lynch International and any of its respective affiliates may from time to time acquire, hold or dispose of Placing Shares and other securities of the Company. Merrill Lynch International does not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

 

Neither Merrill Lynch International nor any of its directors, officers, employees, advisers or agents accepts any responsibility or liability for or makes any representation or warranty, express or implied, as to the truth, accuracy, completeness or sufficiency of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKDBKOBKDODD
Date   Source Headline
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
4th Oct 20224:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:30 pmRNSTotal Voting Rights
14th Sep 20224:30 pmRNSDirector/PDMR Shareholding
9th Sep 202211:00 amRNSHolding(s) in Company
7th Sep 20229:00 amRNSDirector/PDMR Shareholding
31st Aug 20225:00 pmRNSTotal Voting Rights
30th Aug 20224:30 pmRNSDirector/PDMR Shareholding
18th Aug 20225:00 pmRNSDirector/PDMR Shareholding
16th Aug 20224:30 pmRNSDirector/PDMR Shareholding
15th Aug 20227:00 amRNS2022 Half-Year Results
9th Aug 20224:30 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSPhoenix Group to acquire Sun Life UK
29th Jul 20224:00 pmRNSTotal Voting Rights
27th Jul 20223:45 pmRNSHolding(s) in Company
27th Jul 20223:31 pmRNSHolding(s) in Company
7th Jul 20224:45 pmRNSDirector/PDMR Shareholding
1st Jul 20222:00 pmRNSTotal Voting Rights
30th Jun 20224:30 pmRNSBlock Listing Return
29th Jun 20224:00 pmRNSBoard Changes Announcement
27th Jun 20223:15 pmRNSBlocklisting Application Announcement
9th Jun 20223:30 pmRNSDirector/PDMR Shareholding
31st May 20229:30 amRNSTotal Voting Rights
30th May 202211:00 amRNSBlock Listing Application
25th May 20223:00 pmRNSDirector/PDMR Shareholding
16th May 20224:30 pmRNSDirector/PDMR Shareholding
9th May 20223:00 pmRNSDirector/PDMR Shareholding
9th May 20222:15 pmRNSBoard Changes
5th May 20221:14 pmRNSResult of AGM
29th Apr 20225:00 pmRNSTotal Voting Rights
20th Apr 20226:30 pmRNSDirector/PDMR Shareholding
11th Apr 20226:00 pmRNSDirector/PDMR Shareholding
7th Apr 20224:45 pmRNSDirector/PDMR Shareholding
6th Apr 20225:00 pmRNSDirector/PDMR Shareholding
1st Apr 20225:00 pmRNSDirector/PDMR Shareholding
1st Apr 20222:00 pmRNSDirector/PDMR Shareholding
31st Mar 20221:00 pmRNSTotal Voting Rights
30th Mar 20222:00 pmRNSDirector/PDMR Shareholding
25th Mar 20225:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:00 pmRNSNotice of AGM
16th Mar 20226:27 pmRNSDirector/PDMR Shareholding
14th Mar 20227:00 amRNS2021 Annual Financial Report
9th Mar 202211:30 amRNSDirector/PDMR Shareholding
8th Mar 20225:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.